Subscribe to RSS



A. Schulman Inc (NASDAQ:SHLM) Plummets As 2Q Results Miss Expects – SHLM, BAK, HUN, GEVO, FMC

A. Schulman Inc (NASDAQ:SHLM)’s shares plunged on Tuesday after the company’s Q2 results missed analysts’ predictions and it reduced its full-year earnings anticpates.

On late Monday the supplier of plastic compounds and resins declared that adjusted earnings of 27 cents a share on revenue of $522.4M. Analysts polled by FactSet forecasted earnings of 39 cents a share on revenue of $526.4M.

Economic difficulties in Europe and surging competition on price from its peers pressured the performance.

Schulman cut its full-year earnings anticipates between of $2.08 to $2.13 a share for the year against a predict in January of adjusted earnings of $2.14 to $2.19 a share. Analysts had expected adjusted earnings of $2.15 a share for the year.

Shares of A. Schulman Inc (NASDAQ:SHLM) traded at $25.93 by plunging -12.84% with price volatility of 3.86% for a week and 2.47% for a month plus price volatility’s Average True Range for 14 days was 0.93 and its beta stands at 1.26 times.

Stocks after opening at $28.01 hit high price of $28.33 and on last session stock held volume of 1.14 million shares which was unexpectedly higher than its average volume of 121,053 shares.

Short-term as well long term investors always focus on the liquidity of the stocks so for that concern, liquidity measure in recent quarter results of the company was recorded 1.88 as current ratio and on the opponent side the debt to equity ratio was 0.43 and long-term debt to equity ratio also remained 0.36. The Company had total cash at hand $107.14 million and a book value per share as $17.71 in the most recent quarter.

While investors who viewing SHLM against other stocks with the reference of profit margin that are Braskem SA (ADR) (NYSE:BAK) having profit margin -2.93%, Huntsman Corporation (NYSE:HUN) with 3.38% profit margin, Gevo, Inc. (NASDAQ:GEVO) having -155.44% profit margin and FMC Corp (NYSE:FMC) having profit margin of 12.46%.


Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Entire Disclaimer Here

0 comments

Other articlesgo to homepage

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Over-Surged Session Stocks: GW Pharmaceuticals PLC (Nasdaq:GWPH), IntriCon Corp (Nasdaq:IIN), Idera Pharmaceuticals Inc (Nasdaq:IDRA), Intercept Pharmaceuticals Inc (Nasdaq:ICPT), Epizyme Inc (Nasdaq:EPZM)

Shares of GW Pharmaceuticals plc (Nasdaq:GWPH) are trading on different levels, after research firm Morgan Stanley initiated coverage on the company with an Overweight rating and a price target of $103.00 per share. GWPH stock is currently trading for about $63.61, up $17.57 (or +38.16%), with a volume of 4,988,786 shares traded so far. The

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

On-top Session Stocks: BioFuel Energy Corp (Nasdaq:BIOF), LiveDeal Inc (Nasdaq:LIVE), Insteel Industries Inc (Nasdaq:IIIN), SGOCO Group Ltd (Nasdaq:SGOC), SanDisk Corp (Nasdaq:SNDK)

Shares of BioFuel Energy Corp. (Nasdaq:BIOF) skyrocketed on Thursday’s market activity, currently trading for about $8.20, up $2.14 (or +35.30%), and 5,845,868 of its shares exchanged hands so far BioFuel Energy recently received a preliminary non-binding proposal, which suggested the company acquire acquire all of the equity interests in real-estate developer JBGL Capital and JBGL

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Gaining Investiture Session Stocks: Zalicus Inc (Nasdaq:ZLCS), Zogenix Inc (Nasdaq:ZGNX), Lightbridge Corp (Nasdaq:LTBR), Apricus Biosciences Inc (Nasdaq:APRI), Alliqua Inc (Nasdaq:ALQA)

Shares of Zalicus Inc. (Nasdaq:ZLCS) skyrocketed $0.32 (or +31.07%) to $1.35, following the announcement that Epirus Biopharmaceuticals, Inc., which has closed a $36 million Series B financing round, will merge with a wholly-owned subsidiary of Zalicus, to create a global biosimilar enterprise. 13,616,255 shares of Zalicus were traded on Wednesday, increased activity versus its average

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

Momentum Overcomers Session Stocks: SmartPros Ltd (Nasdaq:SPRO), Akebia Therapeutics Inc (Nasdaq:AKBA), WebMD Health Corp (Nasdaq:WBMD), bebe stores inc (Nasdaq:BEBE), Chindex International Inc (Nasdaq:CHDX)

The trading levels of SmartPros Ltd. (Nasdaq:SPRO) stock exploded on Monday’s market activity, closing at $2.99, up $0.77 (or +34.68%), and 334,315 of its shares exchanged hands during the day, a large increase on activity versus its average volume (3m) of 7,818 On intraday trading, SPRO stock reached a new 52 week high of $3.30

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Bullish Prospective Session Stocks: JAKKS Pacific Inc (Nasdaq:JAKK), Rambus Inc (Nasdaq:RMBS), Rentech Inc (Nasdaq:RTK), Oramed Pharmaceuticals Inc (Nasdaq:ORMP), UBIC Inc (Nasdaq:UBIC)

Shares of JAKKS Pacific, Inc. (Nasdaq:JAKK) soared $0.75 (or +9.96%) to $8.28, and 1,043,882 of its shares exchanged hands on Friday’s trading session. JAKKS Pacific, a leading designer and marketer of toys and consumer products, was upgraded from Market Perform to Outperform and its price target raised from $8.00 to $10.00 by brokerage firm BMO

read more

Sign Up*

Receive Our Newsletter!

 



 

 

Contacts and information

Social networks

Most popular categories

© 2014 Crown Equity Holdings Inc. All rights reserved.